APERIOMICS
Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through Deep Shotgun Metagenomic Sequencing, using our world renown database containing over 37,000 microbes. We help doctors and their patients identify the causes of infections that other tests cannot identify, thus s... treamlining the path to a positive clinical outcome. Many patients that we have helped were sick for years with no understanding of why. Patients and their physicians often contact Aperiomics after hearing about our life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.
APERIOMICS
Industry:
Bioinformatics Biotechnology Genetics Health Care Health Diagnostics
Founded:
2013-10-01
Address:
Sterling, Virginia, United States
Country:
United States
Website Url:
http://www.aperiomics.com
Total Employee:
1+
Status:
Active
Contact:
703-229-0406
Email Addresses:
[email protected]
Total Funding:
5.2 M USD
Technology used in webpage:
Amazon Mobile Non Scaleable Content HSTS Nginx Facebook Sharer Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style Apache 2.4 Amazon CloudFront Invalid Certificate Dates
Similar Organizations
Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Invitae
Invitae is a medical genetics company that bring comprehensive genetic information into mainstream medicine to improve healthcare.
Lucence Health
Lucence Health is a liquid biopsy company detecting the hallmarks of cancer for earlier detection and targeted treatment.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Radius Health
Radius Health develops drug therapies for osteoporosis and womenโs health.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tamiami Angel Funds
Tamiami Angel Funds investment in Convertible Note - Aperiomics
Pipeline Angels
Pipeline Angels investment in Series A - Aperiomics
The Launch Place
The Launch Place investment in Series A - Aperiomics
Atlanta Technology Angels
Atlanta Technology Angels investment in Series A - Aperiomics
VentureSouth
VentureSouth investment in Series A - Aperiomics
Central Texas Angel Network
Central Texas Angel Network investment in Series A - Aperiomics
VentureSouth
VentureSouth investment in Series A - Aperiomics
Pipeline Angels
Pipeline Angels investment in Series A - Aperiomics
Propel(X)
Propel(X) investment in Series A - Aperiomics
National Science Foundation
National Science Foundation investment in Grant - Aperiomics
Key Employee Changes
Date | New article |
---|---|
2020-02-05 | Aperiomics Expands Leadership Team with New Chief Operating Officer and Lead Clinical Laboratory Technologist |
More informations about "Aperiomics"
Aperiomics - Crunchbase Company Profile & Funding
Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National โฆSee details»
Aperiomics Company Profile 2024: Valuation, Funding & Investors
Aperiomics General Information Description. Provider of pathogen testing services intended to change the way how infections are identified. The company's offerings include next-generation โฆSee details»
Aperiomics Company Profile - Office Locations, Competitors
Aperiomics is a biotech company providing healthcare and revolutionizing infection testing. The company identifies every bacterium, virus, fungus, and parasite known to modern science โฆSee details»
Aperiomics, Inc. - VentureRadar
Helping doctors and their patients identify the causes of infections that other tests cannot identify, Aperiomics streamlines the path to a positive clinical outcome. Responsible for solving more โฆSee details»
Aperiomics, Inc. Company Profile | Sterling, VA | Competitors ...
Find company research, competitor information, contact details & financial data for Aperiomics, Inc. of Sterling, VA. Get the latest business insights from Dun & Bradstreet.See details»
Aperiomics Inc - Company Profile and News - Bloomberg Markets
Aperiomics, Inc. operates as a biotechnology company. The Company identifies every known bacteria, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using its โฆSee details»
Aperiomics - Lab Manager
Jun 1, 2020 Organization profile for Aperiomics on Lab Manager. Aperiomics Aperiomics combines genomics and informatics in a single test to identify every known pathogen: bacteria, โฆSee details»
Aperiomics - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
Aperiomics quietly sold to Labcorp - Washington โฆ
Feb 14, 2022 Sterling diagnostic startup Aperiomics Inc. has quietly made its exit. The nearly 8-year-old company sold its technology, which pinpoints causes of unsuccessfully diagnosed infections, to ...See details»
Aperiomics - Contacts, Employees, Board Members, Advisors
Organization. Aperiomics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board โฆSee details»
Aperiomics Service Employs Sequencing, Advanced Informatics
Mar 10, 2017 Aperiomics, founded in October 2013 as a spinout from the Computational Biology Institute at George Washington University, has received around $1.5 million from the National โฆSee details»
Biotech Firm Aperiomics Closes $1.8 Million Series A Investment โฆ
STERLING, Va., Aug. 22, 2019 /PRNewswire/ --Aperiomics, the fast-growing biotech company combining the latest advancements in science, technology, and medicine to change the way โฆSee details»
Inside the biotech company hoping to solve medical mysteries
May 2, 2019 The 3rd hour of TODAY looks at the Virginia-based biotech company Aperiomics, which says it has technology that could shake up health care and find answers for the millions โฆSee details»
Aperiomics Expands Leadership Team with New Chief Operating โฆ
Feb 5, 2020 Prior to joining Aperiomics, Ms. Pyle directed the University of Virginia's National Science Foundation Innovation-Corps Program, designing undergraduate and graduate โฆSee details»
Biotech Firm Aperiomics Closes $1.8 Million Series A ... - BioSpace
STERLING, Va., Aug. 22, 2019 /PRNewswire/ --Aperiomics, the fast-growing biotech company combining the latest advancements in science, technology, and medicine to change the way โฆSee details»
New Genomic Tests Aim to Diagnose Deadly Infections Faster
Feb 24, 2020 Dr. Stephen Zekan, a West Virginia surgeon, recently used a test by the company Aperiomics to diagnose what was sickening a 67-year-old woman he initially thought had a tick โฆSee details»
Aperiomics Launches Commercial NGS-based Pathogen Detection โฆ
Nov 18, 2014 Aperiomics launched its commercial sequencing and bioinformatics-based pathogen detection service at the annual meeting of the Association for Molecular Pathology โฆSee details»
Aperiomics Brings Pathogen Testing to Integrative Healthcare Field
May 2, 2017 Aperiomics, Ashburn, Va, recently introduced its infectious disease diagnostic services to the integrative healthcare field at the annual Integrative Healthcare Symposium in โฆSee details»
Pathogen Testing Leader Aperiomics Launches Test for Novel โฆ
STERLING, Va., March 20, 2020 /PRNewswire/ -- Aperiomics, a biotechnology company deploying advanced technologies to identify the root causes of infectious disease, announced โฆSee details»
Pathogen Testing Leader Aperiomics Launches Test for Novel
STERLING, Va., March 20, 2020 /PRNewswire/ --Aperiomics, a biotechnology company deploying advanced technologies to identify the root causes of infectious disease, announced โฆSee details»